We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
+26.72%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$6.52B
AUM Growth
+$1.41B
Cap. Flow
+$327M
Cap. Flow %
5.01%
Top 10 Hldgs %
29.27%
Holding
172
New
29
Increased
68
Reduced
18
Closed
14

Top Buys

Rank Stock Value
1
PRAX icon
Praxis Precision Medicines
PRAX
+$137M
2
VITL icon
Vital Farms
VITL
+$64.9M
3
YETI icon
Yeti Holdings
YETI
+$40.8M
4
GTM
ZoomInfo Technologies
GTM
+$36.8M
5
CWEN icon
Clearway Energy Class C
CWEN
+$32.9M

Top Sells

Rank Stock Value
1
MYOK
MyoKardia, Inc. Common Stock
MYOK
+$84.7M
2
IPHI
INPHI CORPORATION
IPHI
+$51M
3
W icon
Wayfair
W
+$46.2M
4
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
+$37.1M
5
RCKT icon
Rocket Pharmaceuticals
RCKT
+$35.4M

Sector Composition

Rank Sector Weight
1 Healthcare 42.34%
2 Technology 25.33%
3 Industrials 10.16%
4 Consumer Discretionary 6.65%
5 Communication Services 4.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ASND icon
1
Ascendis Pharma A/S
ASND
$16.5B
$284M 4.36%
1,704,148
-5,700
-0.3% -$943K
EXAS
2
DELISTED
Exact Sciences
EXAS
$231M 3.54%
1,740,000
– –
TTD icon
3
Trade Desk
TTD
$8.59B
$218M 3.34%
2,717,180
-297,660
-10% -$22.5M
CRWD icon
4
CrowdStrike
CRWD
$189B
$212M 3.26%
4,009,140
+30,600
+0.8% +$1.19M
FIVN icon
5
FIVE9
FIVN
$2.12B
$204M 3.13%
1,169,268
+10,233
+0.9% +$1.56M
PRAX icon
6
Praxis Precision Medicines
PRAX
$8.58B
$184M 2.82%
+234,205
New +$137M
SRPT icon
7
Sarepta Therapeutics
SRPT
$1.64B
$159M 2.44%
931,512
– –
BHVN
8
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$153M 2.34%
1,783,761
– –
TWLO icon
9
Twilio
TWLO
$29B
$132M 2.03%
391,090
+3,093
+0.8% +$966K
ROP icon
10
Roper Technologies
ROP
$38.5B
$132M 2.02%
306,200
+53,000
+21% +$21.8M
IDXX icon
11
Idexx Laboratories
IDXX
$44.1B
$120M 1.84%
240,000
+39,000
+19% +$17.5M
DT icon
12
Dynatrace
DT
$12.8B
$117M 1.8%
2,714,008
+68,958
+3% +$2.74M
MTD icon
13
Mettler-Toledo International
MTD
$27.9B
$117M 1.8%
103,000
+12,000
+13% +$13.2M
FVRR icon
14
Fiverr
FVRR
$330M
$103M 1.58%
526,971
+10,078
+2% +$1.82M
LRCX icon
15
Lam Research
LRCX
$372B
$96.4M 1.48%
2,040,810
+22,750
+1% +$957K
HUBS icon
16
HubSpot
HUBS
$11.9B
$94M 1.44%
236,987
+1,315
+0.6% +$462K
POOL icon
17
Pool Corp
POOL
$6.95B
$93.8M 1.44%
251,800
+2,000
+0.8% +$698K
GTM
18
ZoomInfo Technologies
GTM
$978M
$91.6M 1.4%
1,898,851
+854,833
+82% +$36.8M
KRTX
19
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$91.5M 1.4%
901,077
– –
W icon
20
Wayfair
W
$11.9B
$90.8M 1.39%
402,000
-174,184
-30% -$46.2M
XIFR
21
XPLR Infrastructure LP
XIFR
$1.12B
$89.5M 1.37%
1,335,200
+60,100
+5% +$3.87M
TT icon
22
Trane Technologies
TT
$97.3B
$88.1M 1.35%
607,100
+17,100
+3% +$2.36M
VRSK icon
23
Verisk Analytics
VRSK
$26.1B
$87M 1.33%
419,300
+85,900
+26% +$16.7M
LOW icon
24
Lowe's Companies
LOW
$118B
$84.5M 1.3%
526,300
+12,000
+2% +$1.95M
ASML icon
25
ASML
ASML
$634B
$83.9M 1.29%
172,000
– –
1
2 3 4 5

Similar funds

HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.08B AUM 16.51% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
CIS
Capital International Sarl Los Angeles, California $6.11B AUM 32.29% 1-Year Est. Return

Eventide Asset Management's Q4 2020 Portfolio in Review

As of Q4 2020, Eventide Asset Management held 172 positions worth $6.52B, up 28% from $5.11B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Eventide Asset Management deployed $327M of net new capital in Q4 2020, opening 29 new positions and adding to 68 existing holdings. Its largest new stake was Praxis Precision Medicines: 234,205 shares worth $184M.

By sector, the portfolio is most concentrated in Healthcare at 42% of assets, up from 41% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Wayfair, an estimated $46.2M trimmed.

  • Eventide Asset Management's largest Q4 2020 buy was Praxis Precision Medicines: 234,205 shares worth $184M.
  • Eventide Asset Management added most to ZoomInfo Technologies in Q4 2020, an estimated $36.8M increase.
  • Eventide Asset Management's biggest Q4 2020 reduction was Wayfair, cutting an estimated $46.2M.
  • Eventide Asset Management fully exited MyoKardia, Inc. Common Stock in Q4 2020, selling an estimated $84.7M.
  • Eventide Asset Management's ten largest holdings make up 29% of its $6.52B portfolio in Q4 2020.
  • Eventide Asset Management opened 29 new positions and closed 14 in Q4 2020.
  • Eventide Asset Management's portfolio value rose 28% quarter-over-quarter to $6.52B.

Based on Eventide Asset Management's 13F filing for Q4 2020, filed 16 Feb 2021.